000			01832 a2200529 4500
005			20250515051307.0
264		0	_c20070119
008			200701s 0 0 fre d
022			_a0755-4982
024	7		_a10.1016/s0755-4982(06)74926-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aBono, Waafa
245	0	0	_a[Localized scleroderma (morphea)]. _h[electronic resource]
260			_bPresse medicale (Paris, France : 1983) _cDec 2006
300			_a1923-8 p. _bdigital
500			_aPublication Type: Comparative Study; English Abstract; Journal Article; Review
650	0	4	_aAdministration, Topical
650	0	4	_aAdrenal Cortex Hormones _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAnti-Inflammatory Agents _xadministration & dosage
650	0	4	_aBalneology
650	0	4	_aChild
650	0	4	_aClinical Trials as Topic
650	0	4	_aClobetasol _xadministration & dosage
650	0	4	_aDermatologic Agents _xadministration & dosage
650	0	4	_aDiagnosis, Differential
650	0	4	_aFemale
650	0	4	_aGlucocorticoids _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aIncidence
650	0	4	_aMale
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aPUVA Therapy
650	0	4	_aPrevalence
650	0	4	_aPrognosis
650	0	4	_aRisk Factors
650	0	4	_aScleroderma, Localized _xclassification
650	0	4	_aSex Factors
650	0	4	_aTacrolimus _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aDupin, Nicolas
773	0		_tPresse medicale (Paris, France : 1983) _gvol. 35 _gno. 12 Pt 2 _gp. 1923-8
856	4	0	_uhttps://doi.org/10.1016/s0755-4982(06)74926-0 _zAvailable from publisher's website
999			_c16728527 _d16728527